Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis.
Ratziu V, de Ledinghen V, Oberti F, Mathurin P, Wartelle-Bladou C, Renou C, Sogni P, Maynard M, Larrey D, Serfaty L, Bonnefont-Rousselot D, Bastard JP, Rivière M, Spénard J; FRESGUN. Ratziu V, et al. Among authors: spenard j. J Hepatol. 2011 May;54(5):1011-9. doi: 10.1016/j.jhep.2010.08.030. Epub 2010 Oct 31. J Hepatol. 2011. PMID: 21145828 Clinical Trial.
NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study.
Berzigotti A, Bellot P, De Gottardi A, Garcia-Pagan JC, Gagnon C, Spénard J, Bosch J. Berzigotti A, et al. Among authors: spenard j. Am J Gastroenterol. 2010 May;105(5):1094-101. doi: 10.1038/ajg.2009.661. Epub 2009 Nov 17. Am J Gastroenterol. 2010. PMID: 19920806 Clinical Trial.
Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study.
Veldhuyzen Van Zanten S, Farley A, Marcon N, Lahaie R, Archambault A, Hunt R, Bailey R, Owen D, Spénard J, Stiglick A, Aimola N, Colin P. Veldhuyzen Van Zanten S, et al. Among authors: spenard j. Can J Gastroenterol. 2000 Jul-Aug;14(7):599-602. doi: 10.1155/2000/690307. Can J Gastroenterol. 2000. PMID: 10978947 Clinical Trial.
Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.
Laine L, Hunt R, El-Zimaity H, Nguyen B, Osato M, Spénard J. Laine L, et al. Among authors: spenard j. Am J Gastroenterol. 2003 Mar;98(3):562-7. doi: 10.1111/j.1572-0241.2003.t01-1-07288.x. Am J Gastroenterol. 2003. PMID: 12650788 Clinical Trial.
Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori.
Lahaie R, Farley A, Dallaire C, Archambault A, Fallone CA, Ponich T, Hunt R, Oravec M, Whitsitt P, Van Zanten SV, Marcon N, Bailey R, Dumont A, Nguyen B, Desrochers S, Spénard J. Lahaie R, et al. Among authors: spenard j. Can J Gastroenterol. 2001 Sep;15(9):581-5. doi: 10.1155/2001/305756. Can J Gastroenterol. 2001. PMID: 11573100 Clinical Trial.
43 results